Jump to content
We need you! See something you could improve? Make an edit and help improve WikSM for everyone.

Iron Supplement

From WikiSM

Alternative Names

  • Iron Supplementation
  • Iron Supplements for Athletes
  • Iron for Athletes
  • Oral Iron Supplement
  • Iron Replacement
  • Iron Replacement Therapy
  • Oral Iron Therapy
  • Iron Tablets
  • Iron Pills
  • Elemental Iron
  • Ferrous Sulfate
  • Ferrous Gluconate
  • Ferrous Fumarate
  • Heme Iron
  • Non-Heme Iron
  • Iron Deficiency Supplement
  • Sports Anemia Supplement

Background

  • This page refers to supplementation of Iron in its various formulations

History

  • Recognition of “sports anemia” emerged in endurance athletes in the mid-20th century, particularly in runners[1]
  • By the 1970s–1980s, research established iron deficiency as a common performance-limiting factor in female and endurance athletes, leading to routine screening and supplementation strategies in sports medicine[2]
  • In the 1990s–2000s, studies clarified the role of iron in aerobic metabolism and VO₂ max, demonstrating that supplementation could improve performance even in non-anemic but iron-depleted athletes[3]
  • Modern research (2010s–present) has focused on hepcidin regulation, timing of supplementation, and individualized dosing strategies[4]

Introduction

Iron Supplement

The impact of iron on the GI tract. Oral iron supplementation causes up to 60% of patients to report gastrointestinal side effects such as constipation, nausea, and bloating. Iron is known to cause intestinal inflammation via the production of ROS. Iron also causes changes to the gut microbiota by increasing the level of enteropathogens and decreasing protective species and may cause changes to archaeal species.[5]

General

  • Iron is essential for oxygen transport via hemoglobin and myoglobin, directly impacting aerobic performance and endurance capacity
  • Athletes—especially endurance athletes, females, and those in weight-sensitive sports—are at higher risk for iron deficiency due to sweat loss, hemolysis, and inadequate intake
  • Iron deficiency exists on a spectrum (low ferritin → iron-deficient erythropoiesis → anemia), with performance decline often occurring before anemia develops
  • Routine screening (e.g., ferritin levels) is commonly used in high-performance settings to identify subclinical deficiency
  • Dietary sources include heme (animal-based, higher absorption) and non-heme (plant-based, lower absorption), often necessitating supplementation in at-risk groups

Formulations

  • Oral – Non-Heme Iron Salts
    • Ferrous sulfate (most commonly used by far)
    • Ferrous gluconate
    • Ferrous fumarate
  • Oral – Other Iron Compounds
    • Ferric citrate
    • Ferric sulfate
    • Polysaccharide iron complex
    • Carbonyl iron
    • Heme iron polypeptide
  • Intravenous (IV) Iron
    • Iron sucrose
    • Ferric carboxymaltose
    • Iron dextran
    • Ferric gluconate

Mechanism

  • Supports hemoglobin synthesis, improves oxygen delivery to working muscles
  • Enhances myoglobin content, improves intramuscular oxygen storage and utilization
  • Facilitates mitochondrial function and oxidative phosphorylation, improves aerobic metabolism
  • Prevents fatigue associated with iron deficiency, maintains training intensity and recovery
  • Restores normal erythropoiesis in deficient athletes, improves VO₂ max and endurance performance

Controversy

  • Supplementation in iron-replete athletes shows inconsistent performance benefits, generally not recommended
  • Risk of gastrointestinal side effects (nausea, constipation) may limit adherence
  • Hepcidin-mediated absorption variability complicates optimal dosing and timing strategies
  • Over-supplementation carries risk of iron overload and oxidative stress
  • Debate exists regarding ideal ferritin thresholds for supplementation in athletes (e.g., <30 vs <50 ng/mL)

Athletic Performance Benefits

Iron Supplement Benefits

Iron Supplement in Athletes

Aerobic Capacity (VO₂ max)[3]

  • ↑ Hemoglobin → ↑ oxygen delivery
  • ↑ VO₂ max in iron-deficient athletes
  • Improves performance even without anemia
  • Supports high-intensity aerobic output

Endurance Performance[6]

  • ↑ Time-to-exhaustion
  • ↑ Sustained submaximal performance
  • Improves running/cycling efficiency
  • Benefits greatest in low ferritin states

Fatigue / Perceived Exertion[7]

  • ↓ Fatigue during training
  • ↓ Perceived exertion (RPE)
  • ↑ Training tolerance
  • Improves daily energy levels

Mitochondrial Function / Energy Metabolism[8]

  • ↑ Oxidative enzyme activity
  • ↑ Mitochondrial efficiency
  • Supports aerobic ATP production
  • Delays onset of fatigue

Recovery & Training Adaptation[4]

  • ↑ Erythropoiesis (red blood cell production)
  • Improves post-exercise recovery
  • Supports adaptation to training load
  • Maintains consistent performance output

Immune Function[9]

  • Supports innate and adaptive immunity
  • ↓ Illness frequency during heavy training
  • Helps maintain training consistency
  • Important in overreaching/overtraining states

Cognitive Function / Focus[10]

  • Improves attention and concentration
  • ↓ Mental fatigue during prolonged activity
  • Supports decision-making in competition
  • Relevant in iron-deficient, non-anemic athletes

Thermoregulation[11]

  • Supports normal temperature regulation
  • May improve heat tolerance in endurance athletes
  • Reduces physiologic strain in hot environments
  • Important for outdoor and high-intensity sports

Muscle Function / Strength[8]

  • Supports muscle oxygenation via myoglobin
  • May improve muscle efficiency
  • Helps prevent performance decline with deficiency
  • Indirect role in strength and power output

Other Health Benefits

Iron Supplementation During Infancy[12]
Oral iron supplements and pathways of absorption. Ferrous iron salts (A) ionize within the intestinal lumen, and iron is then absorbed via the DMT1/FPN pathway. Some ferrous iron may be oxidized and require reduction prior to absorption. The iron–IPC slowly dissolves in the gut lumen (B), thus releasing ferric iron, which is then reduced and absorbed by the DMT1/FPN pathway. Absorption may be less efficient as some iron is liberated from the carbohydrate shell in more distal gut segments. Haem–iron polypeptide (HIP) may be absorbed like dietary haem (C). This process likely involves a BBM haem transporter/receptor, possibly HRG1, intracellular HO1, a reductase and possibly a BLM haem exporter. Details of this process, for haem, or for HIP, remain to be clarified. Amino acids and peptides are known to enhance iron absorption (D). Iron–AA complexation may increase iron bioavailability by delivering iron to the surface of enterocytes, where free iron is absorbed via DMT1. Iron–AA chelates (e.g. Fe‐Gly) may be absorbed intact via AA/peptide transporters (e.g. PEPT1) and then hydrolysed within enterocytes, thus liberating free iron. Sucrosomial iron (SI) and nanoparticle iron (NPI) are likely absorbed via endocytosis, followed by dissociation within lysosomes and iron transport into the cytosol, possibly via DMT1 (E). The lipophilic iron chelate ferric maltol may also be absorbed by this pathway, followed by breakdown in enterocytes or it could traverse cells intact and be taken up by resident tissue macrophages (not shown). There is also evidence that some of these forms of iron can be absorbed via intestinal M cells and then taken up by macrophages of the reticuloendothelial system (RES). Hinokitiol probably allows iron to simply diffuse across membranes, followed by iron release to other iron‐binding ligands within enterocytes (E).[13]
  • Ferrous iron is generally better absorbed than ferric iron[14]

Pregnancy & Fetal Development[15]

  • Reduces risk of maternal anemia and fatigue
  • Supports fetal brain development and growth
  • Decreases risk of low birth weight and preterm delivery

Thyroid Function[16]

  • Supports thyroid hormone synthesis (T3/T4 production)
  • Improves response to iodine supplementation in deficiency states
  • Prevents impaired thyroid metabolism associated with low iron

Dermatologic & Hair Health[17]

  • Supports hair growth and reduces hair shedding in deficiency
  • Improves brittle nails and koilonychia
  • Enhances skin and mucosal integrity

Dosing

  • Typical adult RDA: 8 mg/day for men and 18 mg/day for premenopausal women[14]
  • Adult tolerable upper intake level: 45 mg/day from food and supplements
  • Deficiency dosing commonly uses 40–100 mg elemental iron per dose
  • Alternate-day dosing may improve absorption and tolerability
  • Take with vitamin C or away from calcium when possible

Safety Profile

  • Safe when dosed based on documented deficiency[14]
  • Avoid routine use in iron-replete athletes
  • Monitor ferritin, hemoglobin, and transferrin saturation
  • Use caution with hemochromatosis or iron overload
  • Keep away from children due to overdose risk

Adverse Effects

  • Constipation, nausea, and abdominal discomfort are common[14]
  • Dark stools are expected and benign
  • Diarrhea, vomiting, and metallic taste may occur
  • High doses may cause gastritis or ulcer irritation
  • Severe overdose can cause organ failure or death

Pharmacokinetics

  • Absorption occurs mainly in the duodenum and proximal jejunum
  • Hepcidin decreases intestinal iron absorption
  • Food, calcium, and phytates reduce absorption
  • Iron is transported by transferrin and stored as ferritin

Interactions

  • Calcium can reduce iron absorption[14]
  • Proton pump inhibitors may reduce nonheme iron absorption
  • Iron can reduce levothyroxine absorption
  • Iron may reduce levodopa absorption
  • Separate iron from tetracyclines and fluoroquinolones

WADA Considerations

  • Iron is not listed as a prohibited substance[18]
  • Permitted in and out of competition
  • IV iron should be medically justified and documented
  • Athletes should use third-party tested products
  • Confirm status against the current annual WADA list

See Also


References

  1. Weight, L. M., and P. J. Jacobs. “Athletes’ Pseudoanemia.” Sports Medicine, vol. 11, no. 5, 1991, pp. 289–299.
  2. Haymes, E. M. “Iron Status in Athletes: An Update.” Sports Medicine, vol. 10, no. 2, 1990, pp. 71–83.
  3. 3.0 3.1 Hinton, Pamela S., et al. “Iron Supplementation Improves Endurance after Training in Iron-Depleted, Nonanemic Women.” Journal of Applied Physiology, vol. 88, no. 3, 2000, pp. 1103–1111.
  4. 4.0 4.1 Peeling, Peter, et al. “Iron Considerations for the Athlete: A Narrative Review.” European Journal of Applied Physiology, vol. 114, no. 11, 2014, pp. 2221–2231.
  5. Bloor, Sarah R., Rudolph Schutte, and Anthony R. Hobson. "Oral iron supplementation—gastrointestinal side effects and the impact on the gut microbiota." Microbiology Research 12.2 (2021): 491-502.
  6. Rowland, Thomas, et al. “The Effect of Iron Therapy on the Exercise Capacity of Nonanemic Iron-Deficient Adolescent Runners.” American Journal of Diseases of Children, vol. 142, no. 2, 1988, pp. 165–169.
  7. McClung, James P., et al. “Iron Status and the Female Athlete.” Journal of Trace Elements in Medicine and Biology, vol. 28, no. 4, 2014, pp. 388–392.
  8. 8.0 8.1 Beard, John, and Brian Tobin. “Iron Status and Exercise. ”The American Journal of Clinical Nutrition, vol. 72, no. 2, 2000, pp. 594S–597S.
  9. Beard, John L. “Iron Biology in Immune Function, Muscle Metabolism and Neuronal Functioning.” The Journal of Nutrition, vol. 131, no. 2, 2001, pp. 568S–579S.
  10. McCann, Judith C., and Bruce N. Ames. “An Overview of Evidence for a Causal Relation between Iron Deficiency during Development and Deficits in Cognitive or Behavioral Function.” The American Journal of Clinical Nutrition, vol. 85, no. 4, 2007, pp. 931–945.
  11. Hinton, Pamela S. “Iron and the Endurance Athlete.” Applied Physiology, Nutrition, and Metabolism, vol. 39, no. 9, 2014, pp. 1012–1018.
  12. McMillen, Shasta A., et al. "Benefits and risks of early life iron supplementation." Nutrients 14.20 (2022): 4380.
  13. Ebea‐Ugwuanyi, Pearl O., et al. "Oral iron therapy: current concepts and future prospects for improving efficacy and outcomes." British journal of haematology 204.3 (2024): 759-773.
  14. 14.0 14.1 14.2 14.3 14.4 National Institutes of Health Office of Dietary Supplements. “Iron: Fact Sheet for Health Professionals.” NIH Office of Dietary Supplements, 4 Sept. 2025.
  15. Milman, Nils. “Iron and Pregnancy—A Delicate Balance.” Annals of Hematology, vol. 85, 2006, pp. 559–565.
  16. Zimmermann, Michael B. “The Influence of Iron Status on Iodine Utilization and Thyroid Function.” Annual Review of Nutrition, vol. 26, 2006, pp. 367–389.
  17. Trost, Lara B., et al. “The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss.” Journal of the American Academy of Dermatology, vol. 54, no. 5, 2006.
  18. World Anti-Doping Agency. “The Prohibited List.” WADA, 2026.
Created by:
John Kiel on 28 April 2026 02:40:47
Authors:
Last edited:
5 May 2026 14:58:19
Categories: